ramucirumab,pembrolizumab
eli lilly,merck
['lcsm,(-blcsm)', 'sclc', 'nsclc', 'ramucirumab', 'pembrolizumab']
#asco22 data: 2l pembrolizumab + ramucirumab extends pfs over soc in advanced #nsclc #ascodailynews #lcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.